UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural MesotheliomaEmily S. Reardon, David S. Schrump, William G. Richards et al.|Journal of Thoracic Oncology|2020Cited by 38
Genome-Wide Analysis Identifies Nuclear Factor 1C as a Novel Transcription Factor and Potential Therapeutic Target in SCLCVivek Shukla, David S. Schrump, Haitao Wang et al.|Journal of Thoracic Oncology|2024Cited by 8
The Pluripotency Factor Musashi-2 Is a Novel Target for Lung Cancer TherapyMary R. Zhang, David S. Schrump, Sichuan Xi et al.|Annals of the American Thoracic Society|2018Cited by 7
Hookah Smoke Mediates Cancer-Associated Epigenomic and Transcriptomic Signatures in Human Respiratory Epithelial CellsYin Xiong, David S. Schrump, Sichuan Xi et al.|JTO Clinical and Research Reports|2021Cited by 4
Abstract 7544: Bromodomain and extra-terminal protein inhibitors deplete nuclear factor 1C and reduce stemness and growth of human small cell lung cancer cells in vitro and in vivoHaitao Wang, David S. Schrump, Ruihong Wang et al.|Cancer Research|2024Cited by 0